Dados B3 › RVEE3 × AMER3
RVEE3 × AMER3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | RVEE3 | AMER3 | year |
|---|---|---|---|
| ROE | 0.0%! | -5.6% | 2025 |
| ROIC | 23.7%! | 3.4% | 2025 |
| ROA | 14.1%! | -1.6% | 2025 |
| Gross margin | -421.1% | 27.0% | 2025 |
| EBIT margin | 2,199.6%! | 2.7% | 2025 |
| Net margin | 1,061.9% | -2.2% | 2025 |
| Net debt/EBITDA | — | 0.83x | no year where both have it |
| Current ratio | 4.15x | 1.67x | 2025 |
| Revenue growth (1y) | — | -1.2% | no year where both have it |
| Revenue growth (5y CAGR) | — | 4.0% | no year where both have it |
| Piotroski F-Score | 1/9! | 3/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | RVEE3 | AMER3 | year |
|---|---|---|---|
| P/E | — | -3.81x | 2025 |
| P/B | 0.94x | 0.22x | 2025 |
| EV/EBITDA | — | 1.73x | 2025 |
| FCF yield | — | 34.5% | 2025 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:15 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 06:15 UTC. If this does not match /saude, you are reading a cached copy.